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Introduction
Over a hundred years have passed since Robert
Koch has isolated the tubercle bacillus, but still the
immune mechanisms in tuberculosis are not yet
completely unravelled. The information explosion in
the field of immunology during the last ten years has
resulted in a modest beginning in the knowledge of
tuberculoimmunity at the cellular and molecular
level. It is necessary to understand the host responses
to mycobacterium tuberculosis in order to appreciate
the clinical consequences, diagnosis and prophylaxis
of tuberculous infection. In the following sections
the progress in our understanding of host’s immune
response to M. tuberculosis is considered with
special emphasis on immunopathogenesis, immuno-
suppression and immunodiagnosis.
The clinical and histologic features of any infectious
disease are not only the result of the toxic and invasive
properties of the pathogen but also of the immune
reactions of the host. The first step in the complex
phenomenon is the recognition of the antigens
present on the bacteria as being foreign. There are
two main classes of lymphocytes–the T-lympho-
cytes (thymus derived) and the B-lymphocytes
Bursa or bursa equivalent derived). The B-ceils are
the antibody producing cells. Upon contact with
specific antigen. the B-ceil divides, matures and
differentiates into a plasma cell and synthesizes
antibodies (immunoglobulins). The T-cells on activa-
tion by antigen produce lymphokines. Lymphokines
are biologically active mediators of several immune
responses. Some of the well studied lymphokines
are chemotactic factors, migration inhibitory factors,
mitogenic factors, interferons etc. These lympho-
kines are apparently involved in activation of macro-
phages. The macrophage is the phagocytic cell
which phagocytoses bacteria and particulate matter
and thus plays an important role in aliminating the
pathogen. There is perfect co-ordination among the
three types of cells (macrophage, T-cell and B-cell)
for maintenance of homeostasis.
The antibody response is referred to as the humoral
response whereas that involving T-cells is said to
be cell mediated. Tuberculosis is a classic example
of a disease that is controlled entirely by ceil mediated
immunity involving the macrophage as the effector
ce!l and the lymphocyte as the immunoresponsive cell.
Immunopathogenesis
The complexity of tuberculoimmunity is at least in
part due to the unique features of the bacteria itself.
It produces neither an exotoxin nor an endotoxin.
Its thick lipid coat is responsible for its resistance to
killing by adverse environment–be it inside of the
macrophage or antibodies or drugs. The sulfolipids
of the bacteria is believed to prevent the release of
lysosomal enzymes into the phagosomes of the
macrophage. Its virulence relates to its ability to
survive and proliferate in mononuclear phagocytes.
Several of the bacterial constituents appear to
influence the pattern of host response1.
(1) Cord factors: (trehaloss-6, 6’-dimycolic
acid), the material responsible for the in vitro serpentine
cord like growth of M. tuberculosis, inhibits migration
of leucocytes and stimulates granuloma formation.
(2) High molecular weight lipids and waxes are
probably responsible for much of the tissue reaction
to the bacteria: this may account for its resistance to
killing by lysosomal enzymes and other agents.
(3) Wax-D and tuberculoproteins are associated
with tuberculin hypersensitivity and skin test positivity.
M. tuberculosis is a facultative intra-cellular
organism. Essentially tuberculosis is a struggle bet-
ween the macrophage and the bacillus. Upon entry
into the human host, which is usually by droplet
inhalation, the bacteria is phagocytosed by the
alveolar macrophages. The precise biochemical
events in antigen processing are not understood.
The antigens are then presented to the T-lymphocytes
with the major histocompatibility antigens on the
macrophage surface. The T-cells recognize the anti-
gen and in turn produce lymphokines which are
soluble mediators (Table-1, see appendix) which
through their biologic activity are capable of recruiting
host inflammatory cells, activating them and keeping
them at the site. This leads to the arrival of a large
number of activated macrophages. Some of the
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There are two types of suppressor cells: the first is
a T-cell and can be found following large intravenous
doses of BCG11, M. lepremurium 12 or several
M. avium like organisms11. The second
kind of suppressor cell appears to be the
macrophage which is found in the presence of
heavy systemic loads of mycobacteria or mycobacterial
products and chronic granulomatous lesions12,13,14.
Ellner15 has reported on the suppressive role of
monocytes in tuberculosis. Macrophages produce
factors such as prostaglandins, arginase and thymidine
which in vitro produce suppression of lymphoproli-
feration. However, in tuberculosis it appears to be
tuberculin specific, and acts via cellular interaction with
responding cells apparently by mechanisms not
involving the factors mentioned above.
characteristics of activated macrophages are listed
in Table-2. (see appendix).
The mechanism of intracellular killing of the
bacteria by the macrophage is probably by more than
one way. There are several evidences to show that
hydrogen peroxide and reactive oxygen intermediates
(Superoxide, hydroxylion, Singlet oxygen, etc.),
produced by the macrophage during its metabolism
are detrimental to the organism2,3,4. Gately et al5
have isolated a lymphokine which is capable of 
increasing the intracellular concentration of hydrogen
peroxide. Walker and Lowrie6 have shown increased
intracellular killing by mouse peritoneal macrophages
by hydrogen peroxide which was markedly diminished
upon addition of catalase, an enzyme known to
detoxify hydrogen peroxide.
Interferon- 8, a lymphokine produced by T-lym-
phocytes plays an important role in immune response7.
It has been shown by Murray et aI8 that interferon- 8
enhances intracellular killing of Leishmania donovani
by macrophages both by a hydrogen peroxide depen-
dent and a hydrogen peroxide independent mecha-
nism. It would seem reasonable to determine if
interferon- 8 ( affects killing of M. tuberculosis also.
The cell mediated immunity in tuberculosis is
represented in a simplified form in the figure9 below:
lmmunosuppression
Recently substantial evidence has appeared indicat-
ing that the depressed cellular immunity observed in
mycobacterial diseases is in some instances due to
over activity of suppressor cell systems. The existence
of          sub-populations of lymphocytes which decrease
rather than increase certain immune responses was
first suggested in 197010.
lmmunosuppression has also been attributed to myco-
bacterial components. Ellner16 has shown that myco-
bacterial D-arabino-D-mannan suppresses antigen
induced radiolabelled thymidine incorporation and
migration inhibition factor production by mononuclear
cells. Wadee et al17 have performed elegant in
vitro experiments to show that both the lipid com-
ponents of the tubercle bacillus as well as the sup-
pressor monocytes can cause immunosuppression.
According to Katz et aI18 tuberculous patients have
profound impairment of antibody synthesis following
polyclonal activation with pok weed mitogen in
vitro. This depression appears to be due in part to
the presence of circulating suppressor monocytes
which are capable of suppressing antibody production.
We must admit that the rote for suppressor cells in
the pathogenesis of tuberculosis is poorly understood.
We need to demonstrate the direct involvement of
these suppressive factors in the intracellular killing
of M. tuberculosis. More in-depth studies on specific
immunosuppression is required before one can inter-
pret the present in vitro experiments in terms of
immunosuppression in disease.
Immunodiagnosis
A definitive diagnosis of tuberculous infection
requires the direct demonstration of the bacteria in
the host. Though this is possible in smear positive
pulmonary tuberculosis patients; in smear negative
pulmonary tuberculosis and extra pulmonary tuber-
culosis, it is quite difficult to demonstrate the bacilli
either because they are present in insufficient numbers.
or because of the inaccessibility to the site of lesion as
happens in extra pulmonary tuberculosis.
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The fact that no serodiagnostic test is extensively
carried out at present is a sure indication that all the
tests available have some drawback or the other, the
most important of which is that they are unable to
discriminate between a past. infection or exposure
and active infection. Most of the tests devised so
far have aimed at assaying either a supposedly specific
antibody or less often, antigen. The reason for the
failure of the tests is mainly due to the non-specificity
of the detection systems. This is because many of
the antigens of the tubercle bacillus are shared by
various mycobacterial species and to a lesser extent
by other genera.
The endeavour to serodiagnosis of tuberculosis
dates back to the last century. The important ones
are listed in Table-3 (see appendix). All these tests,
in spite of several modifications; face the problem of
overlap between infected patients and skin test
positive healthy subjects and could not stand the
test of time. With the introduction of enzyme
linked immunosorbent assay and radio immuno assay
the sensitivity of the tests has been well taken care
of i.e., the antigen or antibody can be detected at
nanogram or even picogram levels. The authors’ studies
with enzyme linked immunosorbent assay using PPD
as antigen have not been rewarding. The overlap
of antibody levels between the patients and the
control groups was so much that it was not possible
to discriminate the two groups19.
By applying the technique of radio immuno assay
Kadival20 was able to show a significant difference
in the antigen concentration in the sputum of tuber-
culous and non-tuberculous patients. Sada21 reports
95% specificity and 81.25% sensitivity of detection of
mycobacterial antigens in the cerebrospinal fluid of
tuberculous meningitis patients by enzyme linked
immunosorbent assay.
The prospects of developing more specific tests
for immunodiagnosis are discussed in the section on
scope for future research.
Scope for future research
The immunodeficiency in tuberculosis at the mole-
cular level needs to be known. Only then chemo-
therapy can be coupled with a suitable immunophar-
macologic agent and make treatment more efficient.
At present, it is not known whether the defect lies in
the macrophage per se, which lacks the capacity to
destroy M. tuberculosis or in the T-lymphocyte which
is unable to produce the right lymphokine to stimulate
the macrophage to perform its function. Modern
technology offers a number of tools to study these
functions in vitro. With the advent of the fibre-
optic bronchoscope, macrophages from the lesion can
be obtained which will yield more direct information
about the disease, than peripheral blood cells.
Kohler and Milestein22 have provided us with a
very promising r e s e a r c h   M o n o c l o n a l  a n t i -tool.
bodies produced by the hybridoma technique are
capable of recognising a single epitope in an antigen
molecule. A crude extract of the organisms contain-
ing a large number of various antigens when passed
through an affinity column of a monoclonal antibody
will exclude all the nonspecific ones and retain only
one specific antigen, which can be used for serodia-
gnosis or skin testing. In 1981 Coates et al23
produced eight such monoclonal antibodies and
only one of them (TB-72) has been found specific
for M. tuberculosis H37Rv. TB-68 is specific for
M. tuberculosis H37Rv as well as BCG. TB-72 has
been tried for antibody detection by lvany24 and
found to detect 74% of culture proved tuberculosis
with negligible false negativity. Application of the
recently developed Hybridoma and DNA cloning
techniques in the field of tuberculosis opens up a
new era which may solve many of the unresolved
issues.
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APPENDIX
Products of activated lymphocytes (Table-l ) 1
Migration inhibitory factor.
Macrophage activating factor.
Chemotactic factor for macrophages.
Mitogenic factors.
Factors affecting antibody production, lnterferon.
Activated Macrophages (Table-2) 25
Increase in size.
Increase in cytoplasmic organelles involving
increases in enzymatic activity of mitochondria
and lysosomes.
Increase in membrane mobility
Adherence and spreading
Increase in phagocytosis and pinocytosis
Increase in ability to destroy bacteria
Production of mediators affectors affecting
lymphocytes.
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Table-3 12.
13.
14.
15.
16.
17.
18.
  19.
20.
21.
22.
23.
24.
25.
Bullock, W.E., Carlson, EM., Gershon, R.K. (1978). The
evaluation of immunosuppressive cell populations in experi-
mental mycobacterial infection. J. lmmunol. 120, 1709-1716.
Klimpel, G.R., Henney, C.S. (1978). BCG induced suppressor
cells I. Demonstration of a macrophage like suppressor cell
that inhibits cytotoxic T-cell generation in vitro. J. Immunol,
120, 563-569.
Agglutination test
Complement fixation test
Hemagglutination
Agglutination of inert particle coated with antibody
Precipitation and gel diffusion
Fluorescence antibody test
Enzyme linked immunosorbent assay
Radio immuno assay
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
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